查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2030 年全球微陣列市場預測：按產品、類型、應用、最終用戶和地區進行的全球分析
市場調查報告書
商品編碼
1383449

2030 年全球微陣列市場預測：按產品、類型、應用、最終用戶和地區進行的全球分析

Microarray Market Forecasts to 2030 - Global Analysis By Product (Consumables, Instruments and Software & Services), Type, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球微陣列市場規模將達到 47 億美元，預計到 2030 年將達到 90.4 億美元，預測期內年複合成長率為 9.8%。

在基因組學和分子生物學中，微陣列是一種有效的技術，可以同時高通量研究許多基因、蛋白質和其他物質。該市場由多種類型的微陣列組成，包括 DNA、蛋白質和組織微陣列，在研究、診斷和藥物開發方面提供廣泛的應用。自訂微陣列由多個組織和研究人員創建，以滿足他們獨特的研究需求。

根據英國皇家化學學會 2019 年發表的一項研究，連接到智慧型手機的攜帶式螢光微陣列成像系統正在用於檢測乳癌基因表現。

微陣列在各種應用中的使用增加

由於微陣列被用於各種應用，微陣列市場正在擴大。隨著越來越多的科學家和組織在臨床診斷、蛋白質組學、基因組學和其他領域使用微陣列，對微陣列產品和服務的需求不斷增加。近年來，微陣列已被應用於藥物開發、蛋白質體學、臨床診斷、基因組學和環境監測等更多領域。這種多樣性使得市場對特定產業的變化更具彈性，並使其不斷發展。藥物開發在很大程度上依賴微陣列，因為它們有助於標靶識別、毒性評估和生物標記發現。

與次世代定序儀（NGS）的競爭

次世代定序技術可以獲得完整的分子和基因組資料。因此，微陣列在各種應用中的市場佔有率正在下降。次世代定序儀因其廣泛的資訊和執行高通量測序的能力而經常被研究人員和醫生使用。在考慮技術時，人們很容易認為次世代定序儀比微陣列更強大、更複雜。這種思維方式不利於在研究和其他情況下使用微陣列而支援次世代定序儀，並可能阻礙微陣列業務的擴展。

個人化醫療意識不斷增強

個別患者的分子分析是個人化醫療製化藥物介入的基礎。微陣列對於創建每個患者特有的遺傳和分子資料至關重要。患者和醫療保健專業人員對個體化醫療潛在好處的認知不斷提高，導致對這些技術的需求激增。在個體化醫療領域，研究人員、醫療保健專業人員和生技公司之間的跨學科合作正變得越來越廣泛。

高可維護性

缺乏合格人員可能會阻礙微陣列技術的採用。如果研究機構和臨床實驗室缺乏具備正確操作技術所需技能的員工，他們可能不願意投資微陣列平台。分析微陣列資料很困難，需要生物資訊學知識。缺乏合格的專家可能會導致資料處理效率低下、研究結果延遲或誤解，並減少科學產出。

COVID-19 的影響

微陣列透過研究宿主對病毒的反應、改變患者的基因表現以及創建診斷測試，為 COVID-19 研究做出了貢獻。因此，對基於病毒特異性微陣列的測試的需求增加。因此，疫情導致某些地區的研究資金籌措目標發生變化，重點是疫苗開發和感染疾病研究。此外，一旦大流行的嚴重階段過去，隨著更多資金投入蛋白質體學和基因組學等生命科學研究，微陣列市場可能會成長。

蛋白質微陣列領域預計將在預測期內成為最大的領域

在蛋白質體學研究中，蛋白質微陣列是研究蛋白質的性質、關係和作用的有效且適應性強的工具，因此蛋白質微陣列領域預計將經歷良好的成長。與檢查基因表現的 DNA 微陣列相比，蛋白質微陣列能夠對蛋白質和其他分子之間的結合相互作用進行高通量分析。蛋白質微陣列技術的進步正在產生日益複雜的系統，其靈敏度、特異性和通量也不斷提高。

疾病診斷領域預計在預測期內年複合成長率最高

與遺傳疾病、癌症、感染疾病和染色體異常相關的單核苷酸多態性（SNP）都是使用這些微陣列發現的，使得疾病診斷領域有望在預測期內出現最高的年複合成長率年成長率。這些微陣列使用組織切片和培養細胞來研究各種疾病中的蛋白質-蛋白質相互作用、基因表現模式和蛋白質定位。此外，這些診斷微陣列可以在個人化醫療時代根據患者的遺傳和分子特徵量身定做治療計劃，從而促進市場成長。

比最大的地區

預計亞太地區將在預測期內佔據最大的市場佔有率，因為對尖端醫療保健解決方案的需求不斷成長以及基因組學和個人化醫療研發的加強正在推動市場擴張。亞太地區是積極從事微陣列研究和開發的學術機構、研究機構和生物技術公司的所在地。這包括為特定應用創建微陣列以及識別各種疾病的生物標記。

複合年複合成長率最高的地區：

北美是微陣列技術最大、最發達的市場之一，因此預計在預測期內年複合成長率最高。尤其美國，是微陣列生產和研究的重要中心。北美微陣列市場由許多提供微陣列平台、試劑和服務的跨國和本地公司主導。安捷倫科技、Illumina、Thermo Fisher Scientific、PerkinElmer 等是該領域的主要企業，正在推動該地區的市場成長。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 利害關係人
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章 市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章 全球微陣列市場：依產品

  • 消耗品
  • 裝置
  • 軟體服務

第6章 全球微陣列市場：依類型

  • 蛋白質微陣列
  • DNA微陣列
  • 其他微陣列

第7章 全球微陣列市場：依應用分類

  • 藥物研發
  • 疾病診斷
  • 研究用途
  • 農業
  • 其他用途

第8章 全球微陣列市場：依最終用戶分類

  • 製藥和生物技術公司
  • 研究/學術機構
  • 診斷實驗室
  • 其他最終用戶

第9章 全球微陣列市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東/非洲

第10章 進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章公司簡介

  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific, Inc.
  • Illumina, Inc.
  • PerkinElmer, Inc.
  • Bio-Rad Laboratories
  • GE Healthcare
  • Molecular Devices, LLC
  • Affymetrix
  • Merck & Co., Inc.
  • Arrayit Corporation
  • Microarrays;Inc.
  • NextGen Sciences
  • bioMerieux SA
  • RayBiotech Life, Inc
  • PathogenDx
  • Diasorin Group
  • Schott Minifab
  • Full Moon Biosystems.Inc
  • CapitalBio Technology Co, Ltd
Product Code: SMRC24297

According to Stratistics MRC, the Global Microarray Market is accounted for $4.70 billion in 2023 and is expected to reach $9.04 billion by 2030 growing at a CAGR of 9.8% during the forecast period. In genomics and molecular biology, microarrays are an effective technology that allow for the high-throughput, simultaneous investigation of many genes, proteins, or other substances. The market offers a broad variety of applications in research, diagnostics, and drug development and comprises many types of microarrays, including DNA, protein, and tissue microarrays. Custom microarrays are created by several organizations and researchers to meet their unique research requirements.

According to a research study published by the Royal Society of Chemistry in 2019, a portable fluorescence microarray imaging system that connects to a smartphone has been used for the detection of breast cancer gene expression.

Market Dynamics:

Driver:

Rise in the usage of microarrays in various applications

The market for microarrays has grown as a result of the growing use of microarrays in various applications. The need for microarray goods and services has increased as more scientists and organizations use them for clinical diagnostics, proteomics, genomics, and other areas. These days, microarrays are employed in many more fields, such as drug development, proteomics, clinical diagnostics, genomics, and environmental monitoring due to this diversity, the market is now more resilient to changes in certain industries and has been able to develop continuously. Drug development relies heavily on microarrays because they make target identification, toxicity assessment, and biomarker discovery easier.

Restraint:

Competition from next-generation sequencing (NGS)

Next-generation sequencing technologies can give complete molecular and genomic data; they have become more and more popular. They have so reduced microarrays' market share across a range of applications. Because of Next-generation sequencing breadth of information and high-throughput sequencing capabilities, researchers and physicians frequently use it. When considering technologies, it is frequently thought to be more potent and sophisticated than microarrays. This idea may discourage the use of microarrays in favour of next-generation sequencing in research and other settings, which might stunt the expansion of the microarray business.

Opportunity:

Growing awareness regarding personalized medicines

Molecular profiling of individual patients is the foundation of personalized medicine, which customizes medicinal interventions. In order to produce genetic and molecular data particular to each patient, microarrays are essential. The growing awareness among patients and healthcare professionals of the potential advantages of customized medicine has led to a surge in demand for these technologies. In the realm of customized medicine, interdisciplinary collaboration between researchers, healthcare practitioners, and biotechnology businesses is becoming more widespread.

Threat:

High maintenance

Microarray technology adoption may be hindered by the lack of qualified workers. If research organizations and clinical labs lack the staff with the necessary skills to properly run the technology, they can be reluctant to invest in microarray platforms. The analysis of microarray data might be challenging and call for bioinformatics knowledge. A shortage of qualified experts might lead to ineffective data processing, which would postpone research results, misunderstand them, and decrease scientific output thus hampering the market growth.

COVID-19 Impact

Through the investigation of host responses to the virus, patient gene expression alterations, and the creation of diagnostic tests, microarrays contributed to COVID-19 research. As a result, there was a rise in demand for virus-specific microarray-based tests. Thus, the pandemic caused changes in certain regions' objectives for financing research, with an emphasis on developing vaccines and researching infectious diseases. Furthermore, the market for microarrays may grow if more money is invested in life sciences research, like as proteomics and genomics, once the pandemic's acute phase has passed.

The protein microarrays segment is expected to be the largest during the forecast period

The protein microarrays segment is estimated to have a lucrative growth, as these proteomics research, protein microarrays are an effective and adaptable tool for examining the characteristics, relationships, and roles of proteins. Protein microarrays enable high-throughput analysis of the binding interactions of proteins and other molecules, much to DNA microarrays, which are used to examine gene expression. The advancement of protein microarray technology has produced increasingly sophisticated systems with improved sensitivity, specificity, and throughput.

The diseases diagnostics segment is expected to have the highest CAGR during the forecast period

The diseases diagnostics segment is anticipated to witness the highest CAGR growth during the forecast period, because the single nucleotide polymorphisms (SNPs) linked to genetic disorders, cancer, and infectious illnesses, as well as chromosomal abnormalities, are all found using these microarrays. These microarrays investigate protein-protein interactions, gene expression patterns, and protein localization in a variety of disorders using tissue slices or cultured cells. Moreover these diagnostic microarrays allow for customized treatment plans based on a patient's genetic or molecular profile in the age of personalized medicine thereby boosting the market growth.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to the rising demand for cutting-edge healthcare solutions as well as enhanced genomics and personalized medicine research and development efforts are responsible for this expansion. The Asia Pacific area is home to several academic institutions, research labs, and biotechnology corporations that are actively involved in microarray research and development. This involves the creation of personalized microarrays for particular uses and the identification of biomarkers for a range of illnesses.

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period; owing to one of the biggest and most developed markets for microarray technology. Particularly, the US is a significant centre for microarray creation and research. The North American microarray market is occupied by a number of multinational and local businesses that offer microarray platforms, reagents, and services. Agilent Technologies, Illumina, Thermo Fisher Scientific, PerkinElmer, and many more are some of the major companies in this sector are driving the market growth in this region.

Key players in the market

Some of the key players profiled in the Microarray Market include: Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Illumina, Inc., PerkinElmer, Inc., Bio-Rad Laboratories, GE Healthcare, Molecular Devices, LLC, Affymetrix, Merck & Co., Inc., Arrayit Corporation, Microarrays; Inc., NextGen Sciences, bioMerieux SA, RayBiotech Life, Inc, PathogenDx, Diasorin Group, Schott Minifab, Full Moon Biosystems.Inc and CapitalBio Technology Co, Ltd

Key Developments:

In October 2023, Thermo Fisher Scientific, the world leader in serving science, has introduced the Thermo Scientific™ Meridian™ EX System an electron-beam-based failure analysis solution designed to enable precise fault localization on advanced semiconductor logic technologies.

In October 2023, Thermo Fisher Scientific announced a companion diagnostic (CDx) partnership with Boehringer Ingelheim. Through this collaboration, the companies will work to develop CDx tests to help identify patients with non-small cell lung cancer (NSCLC) with specific genomic mutations.

In September 2023, Agilent Technologies Inc recently signed a Research Collaboration Agreement (RCA) with the National Cancer Centre Singapore (NCCS) outlining their collaboration to accelerate translational cancer research on the genomic landscape of Asian-prevalent cancers over the next two years.

Products Covered:

  • Consumables
  • Instruments
  • Software & Services

Types Covered:

  • Protein Microarrays
  • DNA Microarrays
  • Other Microarrays

Applications Covered:

  • Drug Discovery
  • Diseases Diagnostics
  • Research Applications
  • Agriculture
  • Other Applications

End Users Covered:

  • Pharmaceutical & Biotechnology Companies
  • Research & Academic Institutes
  • Diagnostic Laboratories
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Microarray Market, By Product

  • 5.1 Introduction
  • 5.2 Consumables
  • 5.3 Instruments
  • 5.4 Software & Services

6 Global Microarray Market, By Type

  • 6.1 Introduction
  • 6.2 Protein Microarrays
  • 6.3 DNA Microarrays
  • 6.4 Other Microarrays

7 Global Microarray Market, By Application

  • 7.1 Introduction
  • 7.2 Drug Discovery
  • 7.3 Diseases Diagnostics
  • 7.4 Research Applications
  • 7.5 Agriculture
  • 7.6 Other Applications

8 Global Microarray Market, By End User

  • 8.1 Introduction
  • 8.2 Pharmaceutical & Biotechnology Companies
  • 8.3 Research & Academic Institutes
  • 8.4 Diagnostic Laboratories
  • 8.5 Other End Users

9 Global Microarray Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Agilent Technologies, Inc.
  • 11.2 Thermo Fisher Scientific, Inc.
  • 11.3 Illumina, Inc.
  • 11.4 PerkinElmer, Inc.
  • 11.5 Bio-Rad Laboratories
  • 11.6 GE Healthcare
  • 11.7 Molecular Devices, LLC
  • 11.8 Affymetrix
  • 11.9 Merck & Co., Inc.
  • 11.10 Arrayit Corporation
  • 11.11 Microarrays; Inc.
  • 11.12 NextGen Sciences
  • 11.13 bioMerieux SA
  • 11.14 RayBiotech Life, Inc
  • 11.15 PathogenDx
  • 11.16 Diasorin Group
  • 11.17 Schott Minifab
  • 11.18 Full Moon Biosystems.Inc
  • 11.19 CapitalBio Technology Co, Ltd

List of Tables

  • Table 1 Global Microarray Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Microarray Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Microarray Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 4 Global Microarray Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 5 Global Microarray Market Outlook, By Software & Services (2021-2030) ($MN)
  • Table 6 Global Microarray Market Outlook, By Type (2021-2030) ($MN)
  • Table 7 Global Microarray Market Outlook, By Protein Microarrays (2021-2030) ($MN)
  • Table 8 Global Microarray Market Outlook, By DNA Microarrays (2021-2030) ($MN)
  • Table 9 Global Microarray Market Outlook, By Other Microarrays (2021-2030) ($MN)
  • Table 10 Global Microarray Market Outlook, By Application (2021-2030) ($MN)
  • Table 11 Global Microarray Market Outlook, By Drug Discovery (2021-2030) ($MN)
  • Table 12 Global Microarray Market Outlook, By Diseases Diagnostics (2021-2030) ($MN)
  • Table 13 Global Microarray Market Outlook, By Research Applications (2021-2030) ($MN)
  • Table 14 Global Microarray Market Outlook, By Agriculture (2021-2030) ($MN)
  • Table 15 Global Microarray Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 16 Global Microarray Market Outlook, By End User (2021-2030) ($MN)
  • Table 17 Global Microarray Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
  • Table 18 Global Microarray Market Outlook, By Research & Academic Institutes (2021-2030) ($MN)
  • Table 19 Global Microarray Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
  • Table 20 Global Microarray Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 21 North America Microarray Market Outlook, By Country (2021-2030) ($MN)
  • Table 22 North America Microarray Market Outlook, By Product (2021-2030) ($MN)
  • Table 23 North America Microarray Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 24 North America Microarray Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 25 North America Microarray Market Outlook, By Software & Services (2021-2030) ($MN)
  • Table 26 North America Microarray Market Outlook, By Type (2021-2030) ($MN)
  • Table 27 North America Microarray Market Outlook, By Protein Microarrays (2021-2030) ($MN)
  • Table 28 North America Microarray Market Outlook, By DNA Microarrays (2021-2030) ($MN)
  • Table 29 North America Microarray Market Outlook, By Other Microarrays (2021-2030) ($MN)
  • Table 30 North America Microarray Market Outlook, By Application (2021-2030) ($MN)
  • Table 31 North America Microarray Market Outlook, By Drug Discovery (2021-2030) ($MN)
  • Table 32 North America Microarray Market Outlook, By Diseases Diagnostics (2021-2030) ($MN)
  • Table 33 North America Microarray Market Outlook, By Research Applications (2021-2030) ($MN)
  • Table 34 North America Microarray Market Outlook, By Agriculture (2021-2030) ($MN)
  • Table 35 North America Microarray Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 36 North America Microarray Market Outlook, By End User (2021-2030) ($MN)
  • Table 37 North America Microarray Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
  • Table 38 North America Microarray Market Outlook, By Research & Academic Institutes (2021-2030) ($MN)
  • Table 39 North America Microarray Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
  • Table 40 North America Microarray Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 41 Europe Microarray Market Outlook, By Country (2021-2030) ($MN)
  • Table 42 Europe Microarray Market Outlook, By Product (2021-2030) ($MN)
  • Table 43 Europe Microarray Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 44 Europe Microarray Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 45 Europe Microarray Market Outlook, By Software & Services (2021-2030) ($MN)
  • Table 46 Europe Microarray Market Outlook, By Type (2021-2030) ($MN)
  • Table 47 Europe Microarray Market Outlook, By Protein Microarrays (2021-2030) ($MN)
  • Table 48 Europe Microarray Market Outlook, By DNA Microarrays (2021-2030) ($MN)
  • Table 49 Europe Microarray Market Outlook, By Other Microarrays (2021-2030) ($MN)
  • Table 50 Europe Microarray Market Outlook, By Application (2021-2030) ($MN)
  • Table 51 Europe Microarray Market Outlook, By Drug Discovery (2021-2030) ($MN)
  • Table 52 Europe Microarray Market Outlook, By Diseases Diagnostics (2021-2030) ($MN)
  • Table 53 Europe Microarray Market Outlook, By Research Applications (2021-2030) ($MN)
  • Table 54 Europe Microarray Market Outlook, By Agriculture (2021-2030) ($MN)
  • Table 55 Europe Microarray Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 56 Europe Microarray Market Outlook, By End User (2021-2030) ($MN)
  • Table 57 Europe Microarray Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
  • Table 58 Europe Microarray Market Outlook, By Research & Academic Institutes (2021-2030) ($MN)
  • Table 59 Europe Microarray Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
  • Table 60 Europe Microarray Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 61 Asia Pacific Microarray Market Outlook, By Country (2021-2030) ($MN)
  • Table 62 Asia Pacific Microarray Market Outlook, By Product (2021-2030) ($MN)
  • Table 63 Asia Pacific Microarray Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 64 Asia Pacific Microarray Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 65 Asia Pacific Microarray Market Outlook, By Software & Services (2021-2030) ($MN)
  • Table 66 Asia Pacific Microarray Market Outlook, By Type (2021-2030) ($MN)
  • Table 67 Asia Pacific Microarray Market Outlook, By Protein Microarrays (2021-2030) ($MN)
  • Table 68 Asia Pacific Microarray Market Outlook, By DNA Microarrays (2021-2030) ($MN)
  • Table 69 Asia Pacific Microarray Market Outlook, By Other Microarrays (2021-2030) ($MN)
  • Table 70 Asia Pacific Microarray Market Outlook, By Application (2021-2030) ($MN)
  • Table 71 Asia Pacific Microarray Market Outlook, By Drug Discovery (2021-2030) ($MN)
  • Table 72 Asia Pacific Microarray Market Outlook, By Diseases Diagnostics (2021-2030) ($MN)
  • Table 73 Asia Pacific Microarray Market Outlook, By Research Applications (2021-2030) ($MN)
  • Table 74 Asia Pacific Microarray Market Outlook, By Agriculture (2021-2030) ($MN)
  • Table 75 Asia Pacific Microarray Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 76 Asia Pacific Microarray Market Outlook, By End User (2021-2030) ($MN)
  • Table 77 Asia Pacific Microarray Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
  • Table 78 Asia Pacific Microarray Market Outlook, By Research & Academic Institutes (2021-2030) ($MN)
  • Table 79 Asia Pacific Microarray Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
  • Table 80 Asia Pacific Microarray Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 81 South America Microarray Market Outlook, By Country (2021-2030) ($MN)
  • Table 82 South America Microarray Market Outlook, By Product (2021-2030) ($MN)
  • Table 83 South America Microarray Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 84 South America Microarray Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 85 South America Microarray Market Outlook, By Software & Services (2021-2030) ($MN)
  • Table 86 South America Microarray Market Outlook, By Type (2021-2030) ($MN)
  • Table 87 South America Microarray Market Outlook, By Protein Microarrays (2021-2030) ($MN)
  • Table 88 South America Microarray Market Outlook, By DNA Microarrays (2021-2030) ($MN)
  • Table 89 South America Microarray Market Outlook, By Other Microarrays (2021-2030) ($MN)
  • Table 90 South America Microarray Market Outlook, By Application (2021-2030) ($MN)
  • Table 91 South America Microarray Market Outlook, By Drug Discovery (2021-2030) ($MN)
  • Table 92 South America Microarray Market Outlook, By Diseases Diagnostics (2021-2030) ($MN)
  • Table 93 South America Microarray Market Outlook, By Research Applications (2021-2030) ($MN)
  • Table 94 South America Microarray Market Outlook, By Agriculture (2021-2030) ($MN)
  • Table 95 South America Microarray Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 96 South America Microarray Market Outlook, By End User (2021-2030) ($MN)
  • Table 97 South America Microarray Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
  • Table 98 South America Microarray Market Outlook, By Research & Academic Institutes (2021-2030) ($MN)
  • Table 99 South America Microarray Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
  • Table 100 South America Microarray Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 101 Middle East & Africa Microarray Market Outlook, By Country (2021-2030) ($MN)
  • Table 102 Middle East & Africa Microarray Market Outlook, By Product (2021-2030) ($MN)
  • Table 103 Middle East & Africa Microarray Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 104 Middle East & Africa Microarray Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 105 Middle East & Africa Microarray Market Outlook, By Software & Services (2021-2030) ($MN)
  • Table 106 Middle East & Africa Microarray Market Outlook, By Type (2021-2030) ($MN)
  • Table 107 Middle East & Africa Microarray Market Outlook, By Protein Microarrays (2021-2030) ($MN)
  • Table 108 Middle East & Africa Microarray Market Outlook, By DNA Microarrays (2021-2030) ($MN)
  • Table 109 Middle East & Africa Microarray Market Outlook, By Other Microarrays (2021-2030) ($MN)
  • Table 110 Middle East & Africa Microarray Market Outlook, By Application (2021-2030) ($MN)
  • Table 111 Middle East & Africa Microarray Market Outlook, By Drug Discovery (2021-2030) ($MN)
  • Table 112 Middle East & Africa Microarray Market Outlook, By Diseases Diagnostics (2021-2030) ($MN)
  • Table 113 Middle East & Africa Microarray Market Outlook, By Research Applications (2021-2030) ($MN)
  • Table 114 Middle East & Africa Microarray Market Outlook, By Agriculture (2021-2030) ($MN)
  • Table 115 Middle East & Africa Microarray Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 116 Middle East & Africa Microarray Market Outlook, By End User (2021-2030) ($MN)
  • Table 117 Middle East & Africa Microarray Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
  • Table 118 Middle East & Africa Microarray Market Outlook, By Research & Academic Institutes (2021-2030) ($MN)
  • Table 119 Middle East & Africa Microarray Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
  • Table 120 Middle East & Africa Microarray Market Outlook, By Other End Users (2021-2030) ($MN)